Short-Term Non-Infectious Outcomes After a Pars Plana Intravitreal Antibiotic-Steroid Injection of Triamcinolone, Moxifloxacin, and Vancomycin During Cataract Surgery versus a Standard Postoperative Topical Regimen

References

• Olson RJ, Braga-Mele R, Chen SH, et al. Cataract in the adult eye preferred practice pattern(R). Ophthalmology. 2017;124(2):P1–P119. doi:10.1016/j.ophtha.2016.09.027
   PubMed Web of Science ®Google Scholar
• Packer M, Chang DF, Dewey SH, et al. Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis. J Cataract Refract Surg. 2011;37(9):1699–1714. doi:10.1016/j.jcrs.2011.06.018
   Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026
   PubMed Web of Science ®Google Scholar
• An JA, Kasner O, Samek DA, Levesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40(11):1857–1861. doi:10.1016/j.jcrs.2014.02.037
   PubMed Web of Science ®Google Scholar
• Lindstrom RL, Galloway MS, Grzybowski A, Liegner JT. Dropless cataract surgery: an overview. Curr Pharm Des. 2017;23(4):558–564. doi:10.2174/1381612822666161129150628
   PubMed Web of Science ®Google Scholar
• Endophthalmitis Study Group ESoC, Refractive S. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–988. doi:10.1016/j.jcrs.2007.02.032
   PubMed Web of Science ®Google Scholar
• Shorstein NH, Winthrop KL, Herrinton LJ. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2013;39(1):8–14. doi:10.1016/j.jcrs.2012.07.031
   PubMed Web of Science ®Google Scholar
• Herrinton LJ, Shorstein NH, Paschal JF, et al. Comparative effectiveness of antibiotic prophylaxis in cataract surgery. Ophthalmology. 2016;123(2):287–294. doi:10.1016/j.ophtha.2015.08.039
   PubMed Web of Science ®Google Scholar
• Jabbarvand M, Hashemian H, Khodaparast M, et al. Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology. 2016;123(2):295–301. doi:10.1016/j.ophtha.2015.08.023
   Web of Science ®Google Scholar
• Haripriya A, Chang DF, Namburar S, et al. Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at aravind eye hospital. Ophthalmology. 2016;123(2):302–308. doi:10.1016/j.ophtha.2015.09.037
   PubMed Web of Science ®Google Scholar
• Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology. 2017;124(6):768–775. doi:10.1016/j.ophtha.2017.01.026
   PubMed Web of Science ®Google Scholar
• Chang DF, Braga-Mele R, Henderson BA, et al. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41(6):1300–1305. doi:10.1016/j.jcrs.2015.01.014
   PubMed Web of Science ®Google Scholar
• Gills JP, Gills P. Effect of intracameral triamcinolone to control inflammation following cataract surgery. J Cataract Refract Surg. 2005;31(8):1670–1671. doi:10.1016/j.jcrs.2005.07.023
   Web of Science ®Google Scholar
• Karalezli A, Borazan M, Akova YA. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Acta Ophthalmol. 2008;86(2):183–187. doi:10.1111/j.1600-0420.2007.01114.x
   PubMed Web of Science ®Google Scholar
• Simaroj P, Sinsawad P, Lekhanont K. Effects of intracameral triamcinolone and gentamicin injections following cataract surgery. J Med Assoc Thai. 2011;94(7):819–825.
   Google Scholar
• Chang DT, Herceg MC, Bilonick RA, et al. Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma. Clin Ophthalmol. 2009;3:345–355. doi:10.2147/OPTH.S5730
   Google Scholar
• Meredith TA. Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime. Trans Am Ophthalmol Soc. 1993;91:653–699.
   Google Scholar
• Tyson SL, Bailey R, Roman JS, et al. Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review. Curr Opin Ophthalmol. 2016.
   Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Holladay JT. Visual acuity measurements. J Cataract Refract Surg. 2004;30(2):287–290. doi:10.1016/j.jcrs.2004.01.014
   PubMed Web of Science ®Google Scholar
• Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123(2):316–323. doi:10.1016/j.ophtha.2015.10.001
   PubMed Web of Science ®Google Scholar
• Fisher BL, Potvin R. Transzonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgery. Clin Ophthalmol. 2016;10:1297–1303. doi:10.2147/OPTH.S112080
   Google Scholar
• Kindle T, Ferguson T, Ibach M, et al. Safety and efficacy of intravitreal injection of steroid and antibiotics in the setting of cataract surgery and trabecular microbypass stent. J Cataract Refract Surg. 2018;44(1):56–62. doi:10.1016/j.jcrs.2017.10.040
   Web of Science ®Google Scholar
• McCafferty S, Harris A, Kew C, et al. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmol. 2017;17(1):16. doi:10.1186/s12886-017-0405-7
   PubMed Web of Science ®Google Scholar
• Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgery. Ophthalmology. 2015;122(12):2450–2456. doi:10.1016/j.ophtha.2015.08.024
   PubMed Web of Science ®Google Scholar
• Witkin AJ, Shah AR, Engstrom RE, et al. Postoperative hemorrhagic occlusive retinal vasculitis: expanding the clinical spectrum and possible association with vancomycin. Ophthalmology. 2015;122(7):1438–1451. doi:10.1016/j.ophtha.2015.03.016
   PubMed Web of Science ®Google Scholar
• Cakir B, Celik E, Aksoy NO, et al. Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime. Clin Ophthalmol. 2015;9:493–497. doi:10.2147/OPTH.S74249
   Google Scholar
• Wong DC, Waxman MD, Herrinton LJ, Shorstein NH. Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery. JAMA Ophthalmol. 2015;133(10):1194–1197. doi:10.1001/jamaophthalmol.2015.2421
   Web of Science ®Google Scholar
• Goldberg RA, Flynn HW Jr., Isom RF, et al. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol. 2012;153(2):204–8 e1. doi:10.1016/j.ajo.2011.11.035
   PubMed Web of Science ®Google Scholar
• Cakir M, Imamoglu S, Cekic O, et al. An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery. Curr Eye Res. 2009;34(11):988–995. doi:10.3109/02713680903254822
   PubMed Web of Science ®Google Scholar
• Olavi P. Ocular toxicity in cataract surgery because of inaccurate preparation and erroneous use of 50mg/mL intracameral cefuroxime. Acta Ophthalmol. 2012;90(2):e153–4. doi:10.1111/j.1755-3768.2010.02103.x
   PubMed Web of Science ®Google Scholar